Brought to you by 
Avalon Pharmaceuticals closes $70mm Series B financing
13 Oct 2011
Executive Summary
Avalon Pharmaceuticals (small-molecule cancer drugs) completed its Series B financing round, raising $70mm. Array Capital LLC acted as the placement agent.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com